logo

For the Inventor, By the Inventor

Rockville, MD, United States of America

Neuralstem, Inc.


USPTO Granted Patents = 23

% Expired Patents = 21.7



Forward Citations = 59

Loading Chart...
Loading Chart...

17 inventors (with patents filed for the assignee):

goldMedal Karl K Johe (21 out of 25 patents)

silverMedal Thomas Hazel (8 out of 8 patents)

bronzeMedal Judith Kelleher-Andersson (8 out of 8 patents)

4.  Martin Marsala (4 out of 10 patents)

5.  Osamu Kakinohana (4 out of 4 patents)

6.  Ying Li (2 out of 27 patents)

7.  Sripathy Venkatraman (2 out of 10 patents)

8.  Bingidimi Itute Mobele (2 out of 9 patents)

9.  Olga V Lapina (2 out of 4 patents)

10.  Syed Mahmood (2 out of 2 patents)

11.  Kellie Vercoe (2 out of 2 patents)

12.  Jonathan Salsbury (2 out of 2 patents)

13.  Mark McLaws (2 out of 4 patents)

14.  Shinn-Zong Lin (1 out of 37 patents)

15.  Woei-Cherng Shyu (1 out of 21 patents)


23 patents:

1. 10702555 - Stable neural stem cells comprising an exogenous polynucleotide coding for a growth factor and methods of use thereof (2020-07-07),
2. 10413534 - Amelioration of certain deficiencies due to stroke (2019-09-17),
3. 10322115 - Amelioration of neural deficits associated with diabetes (2019-06-18),
4. 10286010 - Methods of treating neurodegenerative conditions (2019-05-14),
5. 9750769 - Stable neural stem cells comprising an exogenous polynucleotide coding for a growth factor and methods of use thereof (2017-09-05),
6. 9744194 - Methods of treating ischemic spasticity (2017-08-29),
7. 9572807 - Protocols for treatment of major depressive disorder (MDD) (2017-02-21),
8. 9540611 - Methods for treating and/or reversing neurodegenerative diseases and/or disorders (2017-01-10),
9. 9481649 - Synthesis of a neurostimulative piperazine (2016-11-01),
10. 9465025 - Stable neural stem cell lines (2016-10-11),
11. 9278933 - Synthesis of a neurostimulative piperazine (2016-03-08),
12. 9220730 - Methods of treating ischemic spasticity (2015-12-29),
13. 8846914 - Compositions to effect neuronal growth (2014-09-30),
14. 8674098 - Compositions to effect neuronal growth (2014-03-18),
15. 8460651 - Methods of treating amyotrophic lateral sclerosis (ALS) (2013-06-11),
Company Overview
Neuralstem, Inc. is a biotechnology company based in Rockville, Maryland, specializing in the development of innovative therapies for neurological diseases and conditions. The company focuses on stem cell technology and regenerative medicine, aiming to address unmet medical needs in areas such as spinal cord injury, stroke, and neurodegenerative disorders. Through its research and development efforts, Neuralstem seeks to advance the understanding and treatment of complex neurological conditions, leveraging its expertise in cellular therapies.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Neuralstem, Inc. USPTO Patent Assignee Logo
23 Patents

#32 in Rockville, MD

#189 in Maryland

#14,438 in US

#27,714 in the World

Rockville, MD (US)
Rockville, MD, United States of America

Neuralstem, Inc.

Forward Citations = 59

17 inventors:

goldMedal Karl K Johe (21 out of 25 patents)

silverMedal Thomas Hazel (8 out of 8 patents)

bronzeMedal Judith Kelleher-Andersson (8 out of 8 patents)

4.  Martin Marsala (4 out of 10 patents)

5.  Osamu Kakinohana (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Neuralstem, Inc.. Retrieved from https://idiyas.com/company/neuralstem

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…